What was the focus of the ACHIEVE-1 trial
It has shown promise in improving physical endurance, supporting metabolic health, and potentially aiding in weight management Mechanism of Action: MOTS-C influences metabolic pathways by activating AMPK (AMP-activated protein kinase), which promotes glucose utilization, fatty acid oxidation, and energy expenditure
Overall, these findings suggest that PNP-based depots mitigate both systemic and local tissue stress, offering a biocompatible platform for sustained GLP-1 receptor agonist delivery and presenting a promising strategy for long-acting TZP administration that balances efficacy and safety
"Quality Control Standards in GLP-1 Receptor Agonist Manufacturing: A Comprehensive Analysis." International Pharmaceutical Quality Assurance, 2024, Vol
10.1152/physrev.00005.2018 51 HasenfussG.ReineckeH.StuderR.MeyerM.PieskeB.HoltzJ.et al (1994)
i vi nhng bnh nhn thc hin ch n ung lnh mnh v tp luyn nhng vn gp phi tnh trng tng cn, tham kho kin t cc chuyn gia y t l rt quan trng